Goodwin advised HOOKIPA Pharma on the transaction, Shearman & Sterling advised the underwriters. HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics, targeting infectious…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now